Revelation Biosciences Inc (REVB): Investing In A Time Of Crisis

Revelation Biosciences Inc (NASDAQ:REVB) currently has a daily average trading volume of 1.00M but it saw 4539680 shares traded in last market. With a market cap of 2.49M USD, the company’s current market price of $0.30 came falling about -0.63 while comparing to the previous closing price of $0.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.26 and as low as $0.28. In the recent trading on the day, stock has struck highest price mark of $0.2895 while lowest mark touched by it was $0.438.

Taking a look at 20-day trading activity of Revelation Biosciences Inc (REVB) gives us an average price of $0.4706, while its current price level is -98.81% below from 52-week high level whereas it is 6.94% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6950 while that of 200 days or SMA-200 reads an average of $1.4555. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.71% during that period while stretching the period over a month that decreases to 15.49%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.72 which implies that the stock is in oversold territory.

Over the week, REVB’s stock price is moving -6.96% down while it is -58.54% when we observe its performance for the past one month. Year-to-date it is -97.92% down and over the past year, the stock is showing a downside performance of -98.05%.

Currently, Revelation Biosciences Inc’s total number of outstanding shares is 8.36M. Company’s return on investment (ROI) stands at -580.33% and return on equity (ROE) at -270.02%. Stock’s beta reads 0.26. Stock has a price to book (P/B) ratio of 0.48. Its return on asset (ROA) is -148.06% on average.